In Vitro Activities of Rabeprazole, a Novel Proton Pump Inhibitor, and Its Thioether Derivative Alone and in Combination with Other Antimicrobials against Recent Clinical Isolates of Helicobacter pylori

The MICs of rabeprazole sodium (RPZ), a newly developed benzimidazole proton pump inhibitor (PPI), against 133 clinical Helicobacter pylori strains revealed a higher degree of activity than the another two PPIs, lansoprazole and omeprazole. Time-kill curve assays of RPZ, when combined with amoxicill...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kawakami, Yoshiyuki, Akahane, Takayuki, Yamaguchi, Masaru, Oana, Kozue, Takahashi, Yuko, Okimura, Yukie, Okabe, Tadashi, Gotoh, Akira, Katsuyama, Tsutomu
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2000
נושאים:
Susceptibility
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC89707/
https://ncbi.nlm.nih.gov/pubmed/10639386
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים